NR1I2 Antikörper (Internal Region)
-
- Target Alle NR1I2 Antikörper anzeigen
- NR1I2 (Nuclear Receptor Subfamily 1, Group I, Member 2 (NR1I2))
-
Bindungsspezifität
- Internal Region
-
Reaktivität
- Human
-
Wirt
- Ziege
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser NR1I2 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
- Verwendungszweck
- PXR / NR1I2
- Sequenz
- EQFAITLKSY IECNR
- Spezifität
- This antibody is expected to recognize all reported isoforms (NP_071285.1, NP_148934.1, NP_003880.3).
- Kreuzreaktivität
- Human
- Aufreinigung
- Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
- Güteklasse
- Verified
- Immunogen
- Peptide with sequence EQFAITLKSYIECNR, from the internal region of the protein sequence according to NP_003880.3, NP_071285.1, NP_148934.1.
- Isotyp
- IgG
- Top Product
- Discover our top product NR1I2 Primärantikörper
-
-
- Applikationshinweise
-
Immunohistochemistry: Paraffin embedded Human Small Intestine. Recommended concentration: 3.75 μg/mL.
Western Blot: Approx. 48 kDa band observed in lysates of cell line HepG2 (calculated MW of 49.8 kDa according to NP_003880.3). Recommended concentration: 1-3 μg/mL. An additional band of unknown identity was also consistently observed at 35 kDa. This band wa
Peptide ELISA: antibody detection limit dilution 1:4000.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.5 mg/mL
- Buffer
- Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Minimize freezing and thawing.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.
-
- Target
- NR1I2 (Nuclear Receptor Subfamily 1, Group I, Member 2 (NR1I2))
- Andere Bezeichnung
- NR1I2 (NR1I2 Produkte)
- Synonyme
- BXR antikoerper, ONR1 antikoerper, PAR antikoerper, PAR1 antikoerper, PAR2 antikoerper, PARq antikoerper, PRR antikoerper, PXR antikoerper, SAR antikoerper, SXR antikoerper, PXR.1 antikoerper, PXR.2 antikoerper, PXR1 antikoerper, mPXR antikoerper, bxr antikoerper, nr1i2 antikoerper, onr1 antikoerper, xonr1 antikoerper, nuclear receptor subfamily 1 group I member 2 antikoerper, nuclear receptor subfamily 1, group I, member 2 antikoerper, nuclear receptor subfamily 1 group I member 2 S homeolog antikoerper, NR1I2 antikoerper, Nr1i2 antikoerper, nr1i2.S antikoerper, nr1i2 antikoerper
- Hintergrund
- PXR, NR1I2, nuclear receptor subfamily 1, group I, member 2, BXR, ONR1, PAR, PAR1, PAR2, PARq, PRR, SAR, SXR, orphan nuclear receptor, pregnane X receptor, steroid and xenobiotic receptor
- Gen-ID
- 8856
- NCBI Accession
- NP_003880, NP_071285, NP_148934
- Pathways
- Nuclear Receptor Transcription Pathway, Steroid Hormone Mediated Signaling Pathway
-